A multifunctional nanoplatform capable of dual action on tumor PD-L1 for enhanced cancer theranostics
Authors:
- Mengyao MuMMMengyao Mu
- Mengmeng ZhangMZMengmeng Zhang
- Yufang GongYGYufang Gong
- Kai GuoKGKai Guo
- Hui LiuHLHui Liu
- Zeran ZhangZZZeran Zhang
- Tongxin JiangTJTongxin Jiang
- Houren ZhouHZHouren Zhou
- Qing FanQFQing Fan
- Dianlong JiaDJDianlong Jia
- Yuqin LiYLYuqin Li
- Xiao SunXSXiao Sun
- 29 November 2024
- journal article
- research article
- Published by Elsevier in Chemical Engineering Journal
- Vol. 502
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2020MH410)
- Postdoctoral Innovation Project of Shandong Province (SDCX-ZG-202400029)
- National Natural Science Foundation of China (82372031, 22104073)
This publication has 20 references indexed in Scilit:
- Macrophage-mediated immunomodulation in biomaterial-assisted bone repair: Molecular insights and therapeutic prospectsChemical Engineering Journal, 2024
- Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockadeDrug Resistance Updates, 2022
- Nitric Oxide Scavenging and Hydrogen Sulfide Production Synergistically Treat Rheumatoid ArthritisAdvanced Healthcare Materials, 2022
- Tumor Selective Metabolic Reprogramming as a Prospective PD‐L1 Depression Strategy to Reactivate ImmunotherapyAdvanced Materials, 2022
- Embedding Mn2+ in polymer coating on rod-like cellulose nanocrystal to integrate MRI and photothermal functionCarbohydrate Polymers, 2022
- Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responsesImmunity, 2022
- Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blockerCancer Medicine, 2020
- Toward Biomaterials for Enhancing Immune Checkpoint Blockade TherapyAdvanced Functional Materials, 2018
- Hydrogen Sulfide Donors Activated by Reactive Oxygen SpeciesAngewandte Chemie International Edition, 2016
- Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasionCancer Immunology, Immunotherapy, 2006